`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMIVHSSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`wwwusptogov
`
`
`
`
`
`13/383,559
`
`03/23/2012
`
`Takumi Nishimura
`
`050850-11102
`
`3172
`
`James Edward Ledbetter
`
`1875 Eye Street
`Suite 1200
`
`Washington, DC 20006
`
`RANDALL, JR, KELVIN L
`
`3651
`
`MAIL DATE
`
`02/ 1 1/2015
`
`PAPER NUMBER
`
`DELIVERY MODE
`
`PAPER
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`PTOL—90A (Rev. 04/07)
`
`
`
`
`
`Applicant(s)
`Application No.
` 13/383,559 NISHIMURA ET AL.
`
`
`AIA (First Inventor to File)
`Art Unit
`Examiner
`Office Action Summary
`
`
`KELVIN L. RANDALL, JR. [SENS 3651
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address --
`Period for Reply
`
`A SHORTENED STATUTORY PERIOD FOR REPLY IS SET TO EXPIRE g MONTHS FROM THE MAILING DATE OF
`THIS COMMUNICATION.
`Extensions of time may be available under the provisions of 37 CFR1. 136( a).
`after SIX () MONTHS from the mailing date of this communication.
`If NO period for reply is specified above, the maximum statutory period will apply and will expire SIX (6) MONTHS from the mailing date of this communication.
`-
`- Failure to reply within the set or extended period for reply will, by statute, cause the application to become ABANDONED (35 U.S.C. § 133).
`Any reply received by the Office later than three months after the mailing date of this communication, even if timely filed, may reduce any
`earned patent term adjustment. See 37 CFR 1 .704(b).
`
`In no event, however, may a reply be timely filed
`
`Status
`
`1)IZI Responsive to communication(s) filed on 10/16/2014.
`El A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on
`
`2b)|ZI This action is non-final.
`2a)|:l This action is FINAL.
`3)I:I An election was made by the applicant in response to a restriction requirement set forth during the interview on
`
`; the restriction requirement and election have been incorporated into this action.
`
`4)|:| Since this application is in condition for allowance except for formal matters, prosecution as to the merits is
`
`closed in accordance with the practice under Exparte Quay/e, 1935 CD. 11, 453 O.G. 213.
`
`Disposition of Claims*
`
`5)IZI Claim(s) 8,9 and 12 is/are pending in the application.
`5a) Of the above claim(s)
`is/are withdrawn from consideration.
`
`is/are allowed.
`6)I:I Claim(s)
`7)|Z| Claim(s) 8, 9, and 12 is/are rejected.
`8)|:I Claim(s)_ is/are objected to.
`
`
`are subject to restriction and/or election requirement.
`9)I:I Claim((s)
`* If any claims have been determined allowable, you may be eligible to benefit from the Patent Prosecution Highway program at a
`
`participating intellectual property office for the corresponding application. For more information, please see
`hit
`:/'I’\WIIW.usnto. ovI’ atentS/init events/
`
`
`
`iindex.‘s or send an inquiry to PPI-iieedbackf,c‘btisgtc.00v.
`
`Application Papers
`
`10)I:l The specification is objected to by the Examiner.
`11)I:l The drawing(s) filed on
`is/are: a)I:I accepted or b)I:I objected to by the Examiner.
`Applicant may not request that any objection to the drawing(s) be held in abeyance. See 37 CFR 1.85(a).
`
`Replacement drawing sheet(s) including the correction is required if the drawing(s) is objected to. See 37 CFR 1.121 (d).
`
`Priority under 35 U.S.C. § 119
`
`12)I:| Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)-(d) or (f).
`Certified copies:
`
`a)I:l All
`
`b)|:l Some” c)I:l None of the:
`
`1.I:I Certified copies of the priority documents have been received.
`2.|:l Certified copies of the priority documents have been received in Application No.
`3.|:| Copies of the certified copies of the priority documents have been received in this National Stage
`
`application from the International Bureau (PCT Rule 17.2(a)).
`** See the attached detailed Office action for a list of the certified copies not received.
`
`Attachment(s)
`
`
`
`3) D Interview Summary (PTO-413)
`1) D Notice of References Cited (PTO-892)
`Paper No(s)/Mai| Date.
`.
`.
`4) I:I Other'
`2) E InformatIon DIsclosure Statement(s) (PTO/SB/08a and/or PTO/SB/08b)
`Paper No(s)/Mai| Date 07/29/2014.
`US. Patent and Trademark Office
`PTOL—326 (Rev. 11-13)
`
`Office Action Summary
`
`Part of Paper No./Mai| Date 20150208
`
`
`
`Application/Control Number: 13/383,559
`
`Page 2
`
`Art Unit: 3651
`
`DETAILED ACTION
`
`Allowable Subject Matter
`
`1.
`
`The indicated allowability of claims 8, 9, and 12 is withdrawn in view of
`
`reference(s) to JP2006277479 and JP2006277479. Rejections based on the newly
`
`cited reference(s) follow.
`
`2.
`
`Claims 8, 9, and 12 are rejected under pre-AIA 35 U.S.C. 103(a) as being
`
`unpatentable over Omura Yoshito (JP 2006277479 - hereinafter Yoshito) in view of Ken
`
`et al.
`
`(JP 2006277479 — hereinafter Ken).
`
`Re Claim 8:
`
`Yoshito teaches a supplier (30) that temporarily holds a medication (6) accommodated
`
`in a medication storing case (14) and then dispenses the medication to a tray (8) based
`
`on a prescription instruction (paragraph [0015]); a flap (32) provided at a position where
`
`the flap comes into contact with the medication (6) when the medication (6) is taken out
`
`from the medication storing case (14) to the supplier (30) (see Fig. 6a), wherein when
`
`the medication (6) in the medication storing case (14) is taken out to the supplier (30)
`
`based on a prescription instruction, the medication (6) is temporarily stopped by the flap
`
`(32), and after the medication (6) is temporarily stopped, the flap (32) is moved (see Fig.
`
`6b), thereby releasing engagement between the medication (6) and the flap (32) to drop
`
`the medication (6) into the supplier (30); and a holder (Examiner notes that the flap is at
`
`an extended position and thus, is being held — Examiner notes specifically the non-
`
`labeled attachment configuration located on 25b of Fig. 5)) that holds the flap (32) at a
`
`
`
`Application/Control Number: 13/383,559
`
`Page 3
`
`Art Unit: 3651
`
`position where the medication is temporarily stopped and a position where engagement
`
`with respect to the medication (6) is released when the medication (6) in the medication
`
`storing case (14) is taken out to the supplier (30), but fails to specifically teach and show
`
`a holder.
`
`Ken teaches a holder (29, 30) (see Figs. 1-7). Therefore, it would have been obvious
`
`for one of ordinary skill in the art at the time the invention was made to have been
`
`motivated to combine the teachings of Yoshito with that of Ken so as to provide an
`
`alternative holding means for a flap as known within the art.
`
`Further Re Claims 9 and 12:
`
`Yoshito teaches a movable section (25b) disposed at a path where the medication is
`
`taken out from the medication storing case, wherein an inclination angle of the movable
`
`section is changed in an interlocking manner with movement of the flap (see Figs. Ga-
`
`6d).
`
`Conclusion
`
`3.
`
`The prior art made of record and not relied upon is considered pertinent to
`
`applicant's disclosure.
`
`Any inquiry concerning this communication or earlier communications from the
`
`examiner should be directed to KELVIN L. RANDALL, JR. whose telephone number is
`
`
`
`Application/Control Number: 13/383,559
`
`Page 4
`
`Art Unit: 3651
`
`(571 )270-5373. The examiner can normally be reached on Monday-Friday 8:30 AM to
`
`5:00 PM EST.
`
`If attempts to reach the examiner by telephone are unsuccessful, the examiner’s
`
`supervisor, Gene Crawford can be reached on (571)272-6911. The fax phone number
`
`for the organization where this application or proceeding is assigned is 571 -273-8300.
`
`Information regarding the status of an application may be obtained from the
`
`Patent Application Information Retrieval (PAIR) system. Status information for
`
`published applications may be obtained from either Private PAIR or Public PAIR.
`
`Status information for unpublished applications is available through Private PAIR only.
`
`For more information about the PAIR system, see http://pair-direct.uspto.gov. Should
`
`you have questions on access to the Private PAIR system, contact the Electronic
`
`Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a
`
`USPTO Customer Service Representative or access to the automated information
`
`system, call 800-786-9199 (IN USA OR CANADA) or 571-272—1000.
`
`/GENE CRAWFORD/
`
`Supervisory Patent Examiner, Art Unit 3651
`
`/K. L. R./
`
`Examiner, Art Unit 3651
`
`
`
`Application/Control Number: 13/383,559
`
`Page 5
`
`Art Unit: 3651
`
`